首页> 美国卫生研究院文献>Journal of Clinical Oncology >High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

【2h】

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

机译：高移植CD8细胞剂量可预测存活率的提高并在强度降低的条件下进行同种异体干细胞移植中更好的供体选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo characterize the impact of graft T-cell composition on outcomes of reduced-intensity conditioned (RIC) allogeneic hematopoietic stem-cell transplantation (alloHSCT) in adults with hematologic malignancies.

机译：目的表征移植性T细胞组成对血液系统恶性肿瘤成人低强度条件化（RIC）同种异体造血干细胞移植（alloHSCT）结局的影响。

著录项

期刊名称 Journal of Clinical Oncology
作者
Ran Reshef; Austin P. Huffman; Amy Gao; Marlise R. Luskin; Noelle V. Frey; Saar I. Gill; Elizabeth O. Hexner; Taku Kambayashi; Alison W. Loren; Selina M. Luger; James K. Mangan; Sunita D. Nasta; Lee P. Richman; Mary Sell; Edward A. Stadtmauer; Robert H. Vonderheide; Rosemarie Mick; David L. Porter;
展开▼
作者单位

展开▼
年(卷),期 -1(33),21
年度 -1
页码 2392–2398
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning [J] . Reshef Ran, Huffman Austin P., Gao Amy, Journal of Clinical Oncology . 2015 ,第21期

机译：高移植CD8细胞剂量可预测存活率的提高，并在强度降低的条件下进行同种异体干细胞移植中更好的供体选择
2. Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: Does donor T-cell engraftment 3 months after transplant predict survival? [J] . MachaczkaM., JohanssonJ.-E., RembergerM., Leukemia and lymphoma . 2012 ,第9期

机译：降低强度条件的异基因造血干细胞移植在瑞典治疗慢性淋巴细胞性白血病：移植后3个月的供体T细胞植入能否预测存活？
3. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [J] . Armand Philippe, Gannamaneni Supriya, Kim Haesook T., Journal of Clinical Oncology . 2008 ,第35期

机译：降低强度条件的异基因造血干细胞移植后接受西罗莫司用于抗移植物抗宿主病的淋巴瘤患者的存活率提高
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning [O] . Philippe Armand, Supriya Gannamaneni, Haesook T. Kim, -1

机译：降低强度条件的同种异体造血干细胞移植后接受西罗莫司预防移植物抗宿主病的淋巴瘤患者的生存率提高
7. High CD8 Cell Doses Correlate with Reduced Relapse Risk and Improved Survival after Allogeneic Peripheral Blood Stem-Cell Transplantation with Reduced-Intensity Conditioning [O] . Reshef Ran, Luger Selina, Loren Alison, 2014

机译：高强度CD8细胞剂量与降低强度的异体外周血干细胞移植后的复发风险降低和存活率提高相关

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning

摘要

著录项

相似文献

相关主题

期刊订阅